Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor α 2

被引:150
作者
Wood, N
Whitters, MJ
Jacobson, BA
Witek, J
Sypek, JR
Kasaian, M
Eppihimer, MJ
Unger, M
Tanaka, T
Goldman, SJ
Collins, M
Donaldson, DD
Grusby, MJ
机构
[1] Wueth Res, Dept Resp Dis, Cambridge, MA 02140 USA
[2] Wueth Res, Dept Musculoskeletal Sci, Cambridge, MA 02140 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
receptors; immunoglobulin E; interleukin; 13; knockout mice; nitric oxide;
D O I
10.1084/jem.20020906
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin (IL)-13 has recently been shown to play important and unique roles in asthma, parasite immunity, and tumor recurrence. At least two distinct receptor components, IL-4 receptor (R)a and IL-13Ralpha1, mediate the diverse actions of IL-13. We have recently described an additional high affinity receptor for IL-13, IL-13Ralpha2, whose function in IL-13 signaling is unknown. To better appreciate the functional importance of IL-13Ralpha2, mice deficient in IL-13Ralpha2 were generated by gene targeting. Serum immunoglobulin E levels were increased in IL-13Ralpha2(-/-) mice despite the fact that serum IL-13 was absent and immune interferon gamma production increased compared with wild-type mice. IL-13Ralpha2-deficient mice display increased bone marrow macrophage progenitor frequency and decreased tissue macrophage nitric oxide and IL-12 production in response to lipopolysaccharide. These results are consistent with a phenotype of enhanced IL-13 responsiveness and demonstrate a role for endogenous IL-13 and IL-13Ralpha2 in regulating immune responses in wild-type mice.
引用
收藏
页码:703 / 709
页数:7
相关论文
共 38 条
[1]   cDNA cloning and characterization of the human interleukin 13 receptor alpha chain [J].
Aman, MJ ;
Tayebi, N ;
Obiri, NI ;
Puri, RK ;
Modi, WS ;
Leonard, WJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29265-29270
[2]  
Bogdan C, 1997, J IMMUNOL, V159, P4506
[3]   In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice [J].
Bost, KL ;
Holton, RH ;
Cain, TK ;
Clements, JD .
IMMUNOLOGY, 1996, 87 (04) :633-641
[4]   Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain [J].
Caput, D ;
Laurent, P ;
Kaghad, M ;
Lelias, JM ;
Lefort, S ;
Vita, N ;
Ferrara, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16921-16926
[5]   An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response [J].
Chiaramonte, MG ;
Donaldson, DD ;
Cheever, AW ;
Wynn, TA .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (06) :777-785
[6]   Regulation and function of the interleukin 13 receptor α 2 during a T helper cell type 2-dominant immune response [J].
Chiaramonte, MG ;
Mentink-Kane, M ;
Jacobson, BA ;
Cheever, AW ;
Whitters, MJ ;
Goad, MEP ;
Wong, A ;
Collins, M ;
Donaldson, DD ;
Grusby, MJ ;
Wynn, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) :687-701
[7]  
Chiaramonte MG, 1999, J IMMUNOL, V162, P920
[8]   CHEMOATTRACTANTS INDUCE RAPID RELEASE OF THE INTERLEUKIN-1 TYPE-II DECOY RECEPTOR IN HUMAN POLYMORPHONUCLEAR CELLS [J].
COLOTTA, F ;
ORLANDO, S ;
FADLON, EJ ;
SOZZANI, S ;
MATTEUCCI, C ;
MANTOVANI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2181-2188
[9]  
DiSanto E, 1997, J IMMUNOL, V159, P379
[10]  
DOHERTY TM, 1993, J IMMUNOL, V151, P7151